Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.24.27 (
thermolysin
)
1,894
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
5-Methoxytryptoline (5-MeO-
TLN
, 6-methoxytetrahydro-beta-carboline) inhibits with high affinity [3H]-imipramine binding to the
serotonin transporter
in platelets. To evaluate whether 5-MeO-
TLN
is a substrate for the
serotonin transporter
, the accumulation of [3H]-5-MeO-
TLN
into rabbit platelets was studied in vitro. At short incubation times (5 min), [3H]-5-MeO-
TLN
accumulation was temperature-sensitive, but not saturable over a concentration range from 0.06 mumol/l to 10 mumol/l. Moreover, [3H]-5-MeO-
TLN
uptake was not affected by 100 mumol/l ouabain, its structural analogs tryptoline and 5-hydroxytryptoline, nor by the serotonin uptake inhibitors imipramine and citalopram. After longer incubation times (60 min), [3H]-5-MeO-
TLN
accumulation at 0 degree C approached that seen at 37 degrees C and temperature-sensitive [3H]-5-MeO-
TLN
uptake could no longer be observed. It is concluded that temperature-sensitive accumulation of [3H]-5-MeO-
TLN
is not mediated by the
serotonin transporter
and most likely represents a passive, diffusional process, the rate of which is temperature-dependent. The present studies thus confirm the hypothesis that 5-MeO-
TLN
affects [3H]-imipramine binding in platelets through a competitive mechanism and not via an allosteric interaction mediated through the substrate recognition site of the macromolecular complex of
serotonin transporter
.
...
PMID:[3H]-5-methoxytryptoline is not actively accumulated by rabbit platelets. 362 87